Docket Nexus — Federal court records.
Company · Pharmaceuticals & Biotechnology

Regenxbio Inc

Federal civil lawsuits naming Regenxbio Inc, a Pharmaceuticals & Biotechnology company.

Public CompanyPharmaceuticals & Biotechnology
Ticker
Nasdaq: RGNX
Business
Biological Products, (No Diagnostic Substances)
Headquarters
Rockville, MD
SEC CIK
1590877

Regenxbio Inc is a public company in Biological Products, (No Diagnostic Substances), based in Rockville, MD (traded on Nasdaq as RGNX). It appears in 4 federal civil lawsuits in this index, most often as a plaintiff (3 of 4). These cases are most often Patent and Federal Tax / Statutory Actions matters, filed between 2019 and 2026, most frequently in District Court, D. Delaware. The most common causes of action are Patent Infringement, Securities, and Administrative Procedure Act. A frequent opposing party is Sarepta Therapeutics, Inc.

4
Lawsuits
1
As Defendant
3
As Plaintiff
1
Open
3
Terminated
2019–2026
Span
9 mo
Median Duration
0.5 cases/yrPredominantly plaintiff · 75%Patent-heavy · 50%Activity steady

Cases by State

AL — 0 casesAZ — 0 casesAR — 0 casesCA — 0 casesCO — 0 casesCT — 0 casesDE — 2 casesDC — 1 casesFL — 0 casesGA — 0 casesID — 0 casesIL — 0 casesIN — 0 casesIA — 0 casesKS — 0 casesKY — 0 casesLA — 0 casesME — 0 casesMD — 1 casesMA — 0 casesMI — 0 casesMN — 0 casesMS — 0 casesMO — 0 casesMT — 0 casesNE — 0 casesNV — 0 casesNH — 0 casesNJ — 0 casesNM — 0 casesNY — 0 casesNC — 0 casesND — 0 casesOH — 0 casesOK — 0 casesOR — 0 casesPA — 0 casesRI — 0 casesSC — 0 casesSD — 0 casesTN — 0 casesTX — 0 casesUT — 0 casesVT — 0 casesVA — 0 casesWA — 0 casesWV — 0 casesWI — 0 casesWY — 0 cases

Open Cases Over Time

2019peak 2 open2026

Case Types Over Time

20192026
PatentFederal Tax / Statutory ActionsSecurities / Commodities

Filings by Year

20192026

Case Types filter →

Patent2
Federal Tax / Statutory Actions1
Securities / Commodities1

Where Filed filter →

Frequent Opposing Parties

4 Cases — Newest First